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Summary
Background: Cortical stab injury (CSI) induces changes in the
activity, expression and cellular distribution of specific
ectonucleotidases at the injury site. Also, several experimen-
tally induced neuropathologies are associated with changes
in soluble ectonucleotidase activities in the plasma and
serum, whilst various insults to the brain alter purine com-
pounds levels in cerebrospinal fluid, but also in serum, indi-
cating that insults to the brain may induce alterations in
nucleotides release and rate of their hydrolysis in the vascu-
lar system. Since adenine nucleotides and adenosine regu-
late diverse cellular functions in the vascular system, includ-
ing vascular tone, platelet aggregation and inflammatory
responses of lymphocytes and macrophages, alterations of
ectonucleotidase activities in the vascular system may be rel-
evant for the clinical outcome of the primary insult.
Methods: We explored ectonucleotidase activities using spe-
cific enzyme assays and determined adenine nucleotides
concentrations by the UPLC method in the rat serum after
cortical stab injury.
Kratak sadr`aj
Uvod: Ubodna povreda mozga dovodi do promena u
aktivnosti, ekspresiji i }elijskoj distribuciji odre|enih ektonuk-
leotidaza na mestu povrede. Pored toga, neke eksperimen-
talno izazvane neuropatologije povezane su sa promenama
solubilnih ektonukleotidaznih aktivnosti u plazmi i serumu,
dok razli~ite povrede mozga menjaju nivoe purina u cere-
brospinalnoj te~nosti, ali i u serumu, ukazuju}i da povreda
mozga mo`e da dovede do promena u osloba|anju nukleo -
tida i u stepenu njihove hidrolize u vaskularnom sistemu.
Kako adeninski nukleotidi i adenozin reguli{u raznovrsne
}elijske funkcije u vaskularnom sistemu, uklju~uju}i vasku-
larni tonus, agregaciju trombocita i zapaljenski odgovor lim-
focita i makrofaga, promene ektonukleotidaznih aktivnosti u
vaskularnom sistemu mogu biti zna~ajne za klini~ki ishod pri-
marne povrede.
Metode: Primenom specifi~nih enzimskih eseja pratili smo
ektonukleotidazne aktivnosti, a upotrebom UPLC metode
odredili smo koncentracije adeninskih nukleotida u serumu
pacova nakon ubodne povrede korteksa.
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Introduction
Besides having well-known roles in cellular ener-
gy metabolism, adenosine 5’-triphosphate (ATP) is
now recognized as an extracellular signaling molecule
(1). In the central nervous system (CNS), extracellular
ATP exists normally at nanomolar and low micromo-
lar concentrations, when it operates as an excitatory
neurotransmitter (2) or gliotransmitter (3), by acting
at two families of P2 purinoreceptors (4). However,
pathological conditions, such as brain trauma and
ischemia, are associated with massive release of ATP
in the extracellular milieu (5–7), when it operates as
a paracrine factor to activate multiple cellular and bio-
chemical responses to injury, such as activation of
astrocytes and microglia (8, 9). Extracellular ATP is
sequentially hydrolyzed to adenosine, a neuroprotec-
tive and neuromodulatory agent, which suppresses
further release of ATP and other excitatory neuro-
transmitters (10) by acting at P1 receptors (11). Thus,
the enzymes catalyzing the conversion of ATP to
adenosine have a central role in the modulation and
control of ATP and adenosine actions in (patho)phys-
iological conditions.
Extracellular hydrolysis of ATP to adenosine is
mediated by a chain of ectonucleotidase enzymes,
which includes members of the ecto-nucleoside
triphosphate diphosphohydrolase family (NTPDases1-
8) and ecto-nucleotide pyrophosphatase/phospho -
dieste rase family (NPP1-3), which hydrolyze ATP,
either to ade nosine 5’-diphosphate (ADP) or directly
to adenosine 5’-monophosphate (AMP) and ecto-5’-
nucleotidase (eN), which catalyzes the final degrada-
tion of AMP to adenosine. Ectonucleotidases are
membrane-bound ecto-enzymes present in all mam-
malian cells and tissues (12), but they also exist in a
soluble form in the extracellular fluids (13–18), where
they arise from shedding of the membrane-bound
enzymes (13, 19, 20) or from release via microvesi-
cles or exosomes (21).
It has been previously shown that cortical stab
injury (CSI) induces significant changes in the activity,
expression and cellular distribution of NTPDase1 and
eN at the injury site (22–24). It has been shown as
well that experimentally induced neuropathologies are
associated with significant alterations in soluble
ectonucleotidases activity at the periphery, i.e. in the
plasma and serum (16, 25, 28). Namely, variations in
soluble ectonucleotidase activities were observed in
rats with experimentally induced demyelination (25),
autoimmune encephalomyelitis (26) and seizures (27,
28). These findings indicate that insults to the brain,
probably due to disturbed cerebral blood flow, oxida-
tive metabolism or compromised blood–brain barrier,
may induce alterations in nucleotides release and rate
of their hydrolysis in the vascular system. Since ade-
nine nucleotides and adenosine regulate diverse cellu-
lar functions in the vascular system, including vascular
tone, platelet aggregation and inflammatory respons-
es of lymphocytes and macrophages (29), alterations
of ectonucleotidase activities in the vascular system
may be relevant for the clinical outcomes of the pri-
mary insult. Therefore, in this study, we explored alter-
ations in soluble ectonucleotidase activities and serum
levels of adenine nucleotides and nucleosides in a rat
model of cortical stab injury. 
Materials and Methods
Animals
Adult male rats of the Wistar strain (3-month-old,
250–300 g body weight at the time of surgery) were
used in the study. The animals were maintained 3/cage
at constant temperature on a 12 h light/dark cycle with
free access to food and water. The study was per-
formed in accordance with EU Directive 2010/63/EU
for Animal Experiments, whereas all the experimental
protocols were approved by the Institutional Animal
Care Committee. Maximum efforts were made to min-
imize the number of animals used and their suffering.
Surgical procedure
Twenty-five animals were used in the study.
Twenty animals were randomly divided into two
Results: At 4-h post-injury, ATP and AMP hydrolysis increased
by about 60% and 40%, respectively, while phosphodi-
esterase activity remained unchanged. Also, at 4-h post-
injury a marked decrease in ATP concentration and more
than 2-fold increase in AMP concentration were recorded.
Conclusions: CSI induces rapid up-regulation of nucleotide
catabolizing soluble ectonucleotidases in rat serum, which
leads to the observed shift in serum nucleotide levels. The
results obtained imply that ectonucleotidases and adenine
nucleotides participate in the communication between the
brain and the vascular system in physiological and patholog-
ical conditions and thereby may be involved in the develop-
ment of various human neuropathologies.   
Keywords: ectonucleotidases, extracellular adenine nu -
cleo tides, ATP, brain injury, rat serum
Rezultati: ^etiri sata nakon povrede, ATP- i AMP-hidrolizu-
ju}e aktiv nosti bile su povi{ene za pribli`no 60%, odnosno
40%, dok je fosfodiesterazna aktivnost ostala nepromenjena.
Pored toga, 4 h nakon povrede zabele`eno je zna~ajno
pove}anje koncentracije ATP i vi{e nego dvostruko pove}anje
nivoa AMP.
Zaklju~ak: Ubodna povreda mozga dovodi do naglog poras-
ta hidrolizuju}ih aktivnosti solubilnih ektonukleotidaza u seru-
mu pacova, {to vodi uo~enoj promeni nivoa nukleotida.
Dobijeni rezultati pokazuju da ektonukleotidaze i adeninski
nukleotidi posreduju u komunikaciji izme|u mozga i vasku-
larnog sistema, kako u fiziolo{kim tako i u patolo{kim uslovi-
ma, te stoga mogu biti uklju~eni u razvoj razli~itih neuropa-
tologija kod ~oveka. 
Klju~ne re~i: ektonukleotidaze, van}elijski adeninski nu -
kleotidi, ATP, povreda mozga, serum pacova
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groups. Animals of the first group were anesthetized
with ether and positioned in a stereotaxic frame.
Cortical stab injury (CSI) was inflicted by inserting a 1
mm wide dental drill through the skull, 1.5 mm below
the underlying cortical region on the left side (2 mm
lateral from the midline, 2 mm posterior to Bregma),
as previously described (22). The wound was sterile
closed. Animals from another group were anes-
thetized, positioned in the stereotaxic frame and after
making the incision along the midline leaving dura
intact, the wound was sutured (sham surgery group).
All the animals were placed in a heated room and
monitored while recovering from anesthesia. In both
CSI and sham groups, animals were allowed to re -
cover for 4 h and 24 h after the surgery (5
animals/group). Another five age-matched animals
were used as intact controls.  
Isolation of serum
For enzymatic assays, serum samples were pre-
pared as previously described by our group (17).
Blood was drawn after decapitation and was allowed
to clot at room temperature for 30 min. Blood was
centrifuged in plastic tubes at 2000 × g for 5 min.
The resultant serum samples were kept separately at
–80 °C. Serum protein content was determined by the
method of Bradford (30). 
For ultra performance liquid chromatography
assays (UPLC) serum samples were prepared as pre-
viously described (17). Briefly, serum protein content
was precipitated by adding 0.6 mol/L perchloric acid
(PCA) and by subsequent centrifugation at 14 000 ×
g for 10 min. Supernatants were neutralized by 4.0
N NaOH and clarified with second centrifugation at
14 000 × g for 15 min. Resultant supernatants were
kept at –80 °C until use.
Enzyme assays
Soluble ectonucleotidase activities were
assayed using a modification of the method of Oses
et al. (16) as previously described (26). For ATP and
ADP hydrolysis, the reaction mixture contained (in
mmol/L): 112.5 Tris-HCl, pH 8.0, 0.5 EDTA, 5
MgCl2 and 0.5 mg of serum proteins in the final vol-
ume of 200 mL. For AMP hydrolysis, the reaction mix-
ture contained (in mmol/L): 112.5 Tris-HCl, pH 8.0,
10 MgCl2 and 0.5 mg of serum proteins. Reaction
was initiated by the addition of ATP, ADP or AMP in
the final concentration of 0.5 mmol/L and allowed to
proceed for 40 min at 37 °C. The reaction was
stopped by the addition of 3 mol/L PCA and by trans-
ferring the test tubes on ice. Level of non-enzymatic
hydrolysis was determined for each sample by adding
an aliquot of serum after the reaction was stopped
with PCA. All the samples were centrifuged at 5000
× g for 5 min at 4 °C to eliminate precipitated pro-
tein and the supernatant was used for the colorimet-
ric determination of inorganic phosphate (Pi) by the
malachite green method (31). Rate of nucleotide
hydrolysis was expressed as mean specific activity
(nmol Pi/mg/min) ± SEM, from n=2 determinations
performed in quintuplicate in five different serum
samples for each time and surgical procedure group. 
Soluble nucleotide pyrophosphatase/phospho-
diesterase activity was assessed by measuring phos-
phodiesterase activity using p-nitrophenyl thymidine
5’-monophosphate (p-Nph-5’-TMP) as a substrate
(17). Briefly, reaction mixture, containing (in mmol/L)
0.5 p-Nph-5’-TMP in 100 Tris-HCl, pH 8.9, was incu-
bated with 1 mg of serum protein, for 5 min at 37 °C,
in the final volume of 200 mL. The reaction was
stopped by the addition of 0.2 mol/L NaOH and the
amount of p-nitrophenol (p-Nph) liberated as a result
of the enzyme activity was measured at 400 nm using
an extinction coefficient of 27.4 × 10-3 (L mol-1
cm-1). Level of non-enzymatic hydrolysis was deter-
mined for each sample by adding serum in the stan-
dard reaction mixture after the reaction was stopped
with NaOH. Rate of phosphodiesterase activity was
expressed as mean specific activity (nmol p-
Nph/mg/min) ± SEM from n=4 determinations per-
formed in triplicate in five different serum samples for
each time and surgical procedure group.
Ultra performance liquid chromatography
(UPLC)
For the UPLC assay, an aliquot of each sample (2
mL) was injected to the UPLC system and separated by
ACQUITY UPLCTM BEH C18 100 mm × 2.1 mm col-
umn (Waters, Milford, USA), kept at 40 °C with 4
mmol/L tetrabutylammonium hydroxide in 4 mmol/L
phosphate buffer (A) and methanol (B), in the ratio
A:B = 3:1, as a mobile phase. Under these conditions
adenine nucleotides were readily separated and
detected by a TUV detector at 254 nm. Com pounds
of interest, ATP, ADP, AMP, adenosine were identified
and quantified by using corresponding freshly pre-
pared ultra pure standards of known concentrations to
determine retention times for each compound and for
the construction of calibration curves. Analyte concen-
trations are given in mmol/L serum. 
Data analysis
Results are expressed as mean ± SEM of n inde-
pendent experiments. Comparison between different
groups (CSI vs. intact control and CSI vs. sham) was
made by Student’s t test for independent samples, fol-
lowed by Tukey test for multiple comparisons among
means. Differences between CSI and sham or CSI
and intact control group were considered significant
at level p<0.05. 
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Results
Ectonucleotidase enzyme assays
Rates of soluble ectonucleotidase activities fol-
lowing CSI were assessed using enzyme-specific
assays. NTPDase activity was assessed by determin-
ing the rates of ATP (Figure 1A) and ADP (Figure 1B)
hydrolysis, whereas eN activity was assessed by deter-
mining the rate of AMP hydrolysis in serum samples
(Figure 1C). The rates of soluble ATP, ADP and AMP
hydrolysis in intact control animals were 0.14±0.01
nmol Pi/mg/min, 0.25±0.03 nmol Pi/mg/min and
0.45±0.04 nmolPi/mg/min, respectively. Rates of
nucleotide hydrolysis significantly changed at 4-h
post-injury, when almost 60% increase in ATP hydro -
lysis (p<0.005) and 40% increase in AMP hydrolysis
(p<0.005) were observed in respect to the corre-
sponding sham controls, whereas at 24-h post-injury
both ATP and AMP hydrolysis returned to the control
values. The rate of ADP hydrolysis remained un -
changed after the injury. 
Soluble nucleotide pyrophosphatase/phospho-
diesterase activity in the serum was determined using
p-nitrophenyl thymidine 5’-monophosphate as a sub-
strate (Figure 1D). NPP activity in the serum samples
of intact control animals was 1.78±0.04 nmol p-
Nph/mg/min. NPP activity in CSI group did not vary
in respect to sham control group during the 24-h
post-injury period.
Determination of adenine nucleotide and purine
concentrations by UPLC 
Serum samples were analyzed by the UPLC sys-
tem with a TUV detector and the representative chro-
matogram of intact control samples is shown in Figure
2. Eight chromatographic peaks were assigned: (1)
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Figure 1 Soluble ectonucleotidase activity after the injury.
A–C: Soluble nucleotide hydrolysis was assayed in the presence of 0.5 mmol/L ATP (A), ADP (B) and AMP (C), whilst nucleotide
phosphodiesterase activity (D) was assessed using 0.5 mmol/L p-Nph-5’-TMP  as a substrate. Serum samples were obtained from
CSI (shaded bars) and sham group (white bars) at different post-injury times (4-h and 24-h). Bars represent mean activity (nmol
Pi/mg/min) ± SEM (A–C), and (nmol p-nitrophenol/mg/min) ± SEM (D) from n=2 determinations in five different samples for
each time and surgery group, assayed in quintuplicate (A–C) and triplicate (D). Dot line indicates mean activity in serum samples
obtained from intact control animals ± SEM (gray areas). Statistical significance was determined in respect to intact control group
(# p<0.05) and sham group (**p<0.005) in serum samples obtained from CSI animals at different post-injury times. 
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inosine (0.93 min), (2) xanthine (1.15 min), (3)
adenosine (1.24 min), (4) hypoxanthine (1.51 min),
(5) AMP (1.74 min), (6) ADP (4.01 min) and (7) ATP
(6.12 min). Peak d was assigned to GTP by co-elution
of relevant standard solution, even though its amount
could not be determined. Peaks a, b and c require fur-
ther investigation to be identified. Results obtained by
quantitative analysis of chromatographic data are
shown in Table I. Basal levels of ATP, ADP and AMP
were in the submicromolar range, whereas concentra-
tions of adenosine and its downstream metabolites –
inosine, hypoxanthine and xanthine, were about one
order of magnitude higher. Analyte concentrations in
intact control serum samples have shown a quite nar-
row range of individual variability and were compara-
ble with those reported in the literature (32, 33). 
Concentrations of analytes in serum samples at
different post-injury times are shown in Table I. At
4-h post-injury, about 20% decrease in ATP concen-
tration (p<0.05), together with more than 2-fold
increase in AMP concentration were observed in
respect to control group. At the same time point,
about 25% decrease in inosine (p<0.05) and corre-
sponding increase in xanthine concentration (p<
0.001) in respect to sham control were detected. At
24-h post-injury concentrations of tested analytes
returned to control level. 
Discussion
Reciprocal interactions between the brain and
the vascular system in health and disease have drawn
considerable attention, mostly concerning the identi-
ty of signaling molecules and networks that mediate
this bi-directional relationship (34, 35). Among many
endogenous signaling factors, extracellular adenine
nucleotides and nucleosides are now considered as
true mediators between the two systems (35). Several
groups reported that insult to the brain alters purine
compound levels, not just in the cerebrospinal fluid
(36, 37), but also in serum (32, 38). Changes in the
rate of soluble (21, 25, 26) and membrane-bound
ectonucleotidase activities (39) were also observed in
the vascular system of humans and animals with dif-
ferent neuropathologies. Therefore, the aim of the
present study was to explore the serum levels of ade-
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Figure 2 Representative UPLC chromatogram of serum of
intact control samples. 
Aliquots (2 mL) of protein-free samples were separated by
ACQUITY UPLCTM BEH C18 100 mm × 2.1 mm column
(Waters) and detected by TUV detector at 254 nm. Analytes
of interest were identified and quantified by using freshly pre-
pared ultra pure standards of known concentrations. The
identity of chromatographic peaks was confirmed by co-injec-
tion of genuine samples of the nucleotides, nucleosides and
oxypurines. Peaks: (1) – Inosine; (2) – Xanthine; (3) – Ade -
nosine; (4) – Hypoxanthine; (5) – AMP; (6) – ADP; (7) – ATP.
For peaks a, b, c and d, see text. 
Table I Adenine nucleotides and purine compounds level in serum.
UPLC measurements of adenine nucleotides ATP, ADP and AMP, adenosine (Ado), inosine (Ino), hypoxanthine (Hypo) and xan-
thine (Xanth) concentrations in serum of intact control animals and animals subjected to CSI or sham surgery at different post-
injury times. Data are mean concentrations (mmol/l serum) from n=2 determinations in 5 serum samples per time and surgery
group. Different from intact control group, # p<0.05; ## p<0.001; different from sham group, * p<0.05; ** p<0.001.
Concentration (mmol/L serum)  
Analyte ATP ADP AMP Ado Ino Hypo Xanth  
Intact control 0.25±0.02 0.31 ±0.11 0.39±0.04 2.76±0.26 2.63±0.12 3.41±0.04 3.71±0.12
4-h     Sham 0.20±0.03 0.34±0.07 0.58±0.13 2.39±0.32 2.96±0.11 3.47±0.41 3.46±0.31
CSI 0.16±0.01# 0.24±0.03 0.96±0.21# 2.51±0.42 2.29±0.16* 3.58±0.47 4.67±0.15**##
24-h    Sham 0.30±0.05 0.28±0.04 0.51±0.17 2.15±0.40 2.75±0.12 3.17±0.48 3.49±0.05
CSI 0.34±0.07 0.28±0.02 0.46±0.04 1.87±0.27 2.58±0.05 3.12±0.18 3.09±0.11
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nine nucleotides and nucleosides as well as the activ-
ities of soluble ectonucleotidases after brain injury, in
order to elucidate their potential role in the relation-
ship between the nervous and the vascular system
under physiological and pathological conditions. 
Considering basal purine levels in serum, submi-
cromolar concentrations of nucleotides in respect to
approximately ten-times higher levels of nucleosides
and oxopurines were determined, suggesting pre-
dominance of nucleotide-catabolizing over nucleo -
tide-regenerating pathways in the vascular system in
physiological conditions. It was further found that uni-
lateral cortical stab injury induces dynamic changes in
the serum levels of adenine nucleotides and purine
compounds, probably resulting from sequential acti-
vation of the two opposite pathways of purine meta -
bolism. Namely, as early as 4 h post-injury, ATP and
inosine concentrations decreased, while AMP and
xanthine concentrations increased, suggesting up-
regulation of enzymes that mediate ATP hydrolysis in
serum early after the injury. Alterations obtained may
arise from increased energy demands caused by
injury, since increase in plasma levels of purine bases
such as xanthine or hypoxanthine are considered as
an indicator of energy stress (32). In particular, deple-
tion of extracellular ATP may be related to excessive
consumption by vascular cells, while AMP may act as
a signaling molecule at P1 receptors (40) to potenti-
ate energy-preserving pathways (37). Variations in
serum nucleo tide levels at 4-h post-injury were in
close correlation with changes in the rate of ectonu-
cleotidase activities, namely, at the same time point,
ATP-hydrolysis significantly increased. Since phospho-
diesterase activity remained unchanged after the
injury, implying that NPP soluble forms are not
involved in the increased ATP hydrolysis in serum, it is
most likely that the up-regulation of soluble
NTPDase1, which hydrolyzes ATP directly to AMP,
mostly contributes to the change obtained. Increase
in AMP hydrolysis at 4-h post-injury implies up-regu-
lation of soluble eN, which is the only enzyme that
converts AMP to adenosine. On the other hand, 24-h
post-injury, both purine concentrations and nucleo -
tide-hydrolysing activities in serum returned to the
control level, additionally confirming the key role of
ectonucleotidases in the regulation of adenine
nucleotide levels in blood. Up-regulation of ATP and
AMP hydrolysis rates in rat serum were previosly
observed in several seizure models (27, 28), implying
that injury to the brain generates changes in the
catabolism of adenine nucleotides in the vascular sys-
tem. Interestingly, in our study, the adenosine level in
serum remained stable during the whole post-injury
period, although increased levels of this tissue-protec-
tive and immuno-supressive nucleoside (41) were re -
peatedly found in the cerebrospinal fluid in several in
vivo models of brain injury (7, 36). Since the adeno-
sine level in extracellular milieu results from two
opposite activities, namely from adenosine-producing
eN activity and adenosine-eliminating activity cat-
alyzed by adenosine deaminase, the stable serum
adenosine level might reflect a balance between the
two activities. Even though adenosine metabolizing
enzymes (42) were not the subject of this study, it is
worth noting that the serum levels of adenosine
metabolites, inosine and xanthine, were significantly
altered 4-h after the injury. Beside enzymatic degra-
dation, the stable serum adenosine level could be
also maintained by nucleoside transporters (43),
which mediate either facilitated or Na+-coupled
adenosine transport back to the cells of the vascu -
lature or, through the endothelial wall of the
blood–brain barrier, to the brain parenchyma.
Anyhow, unchanged serum adenosine level indicates
the existence of a stable adenosine pool continually
available for the purine recycling pathway (42). 
Since ATP acts as a ligand at multiple P2 recep-
tors, alterations in its serum concentration after the
injury may affect numerous cellular functions. For
instance, at high micromolar concentrations, ATP
promotes vasodilatation (4) and triggers proinflam-
matory effector functions (4, 44) including produc-
tion of proinflammatory cytokines (45–47).
To summarize the results of the study, brain
injury induces dynamic changes in serum purine levels
as well as an increase in soluble nucleotide-hy dro -
lysing activities. Early after the injury, enhanced
ATP-hydro lysis, probably due to the up-regulation of
NTPDase1, produces a decrease in ATP and an in -
crease in AMP levels in blood. Changes in nucleotide
concentration and their ratios affect the type and dura-
tion of P2 receptor activation and shape many effector
functions in the vascular system, including the blood
flow and responses of vascular endothelial, immune
and blood cells. Thus, the results of our study imply
that adenine nucleotides and ectonucleotidases may
be the members of a communication network bet -
ween the brain and the vascular system in physiologi-
cal and pathological conditions, and thereby involved
in the development of various human neuropatholo-
gies.  
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